Studying the Microbiome: Omics Made Accessible

Seminars in Liver Disease

Volumn 36, Issue 4, 2016, Pages 306-311

  O'Toole, Paul W ^a   Flemer, Burkhardt ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

intestinal disease; microbiome; microbiota

Indexed keywords

GLUCOSE; RNA 16S; BIOLOGICAL MARKER;

AMPLICON; ARTICLE; COLON CANCER; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; INTESTINE FLORA; IRRITABLE COLON; MANAGED CARE; METAGENOMICS; METATRANSCRIPTOMICS; MICROBIOLOGICAL EXAMINATION; MICROBIOME; MICROFLORA; NONHUMAN; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCREENING TEST; TRANSCRIPTOMICS; BACTERIUM; CLASSIFICATION; GASTROINTESTINAL TRACT; MICROBIOLOGY; SEQUENCE ANALYSIS;

BACTERIA; BIOMARKERS; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; SEQUENCE ANALYSIS, RNA;

EID: 85006880852     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0036-1594008     Document Type: Article

References (65)

1. Gullett J. C., Nolte F. S. Quantitative nucleic acid amplification methods for viral infections. Clin Chem: 2015; 61 1 72 78
2. Browne H. P., Forster S. C., Anonye B. O., et al. Culturing of 'unculturable' human microbiota reveals novel taxa and extensive sporulation. Nature: 2016; 533 7604 543 546
3. Walker A. W., Duncan S. H., Louis P., Flint H. J. Phylogeny, culturing, and metagenomics of the human gut microbiota. Trends Microbiol: 2014; 22 5 267 274
4. Rigottier-Gois L., Bourhis A. G., Gramet G., Rochet V., Doré J. Fluorescent hybridisation combined with flow cytometry and hybridisation of total RNA to analyse the composition of microbial communities in human faeces using 16S rRNA probes. FEMS Microbiol Ecol: 2003; 43 2 237 245
5. Mueller S., Saunier K., Hanisch C., et al. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol: 2006; 72 2 1027 1033
6. Zoetendal E. G., Rajilic-Stojanovic M., de Vos W. M. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut: 2008; 57 11 1605 1615
7. Kassinen A., Krogius-Kurikka L., Mäkivuokko H., et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology: 2007; 133 1 24 33
8. Manichanh C., Rigottier-Gois L., Bonnaud E., et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut: 2006; 55 2 205 211
9. Consortium H. MP.; Human Microbiome Project Consortium. A framework for human microbiome research. Nature: 2012; 486 7402 215 221
10. Qin J., Li R., Raes J., et al. MetaHIT Consortium. A human gut microbial gene catalogue established by metagenomic sequencing. Nature: 2010; 464 7285 59 65
11. Faust K., Sathirapongsasuti J. F., Izard J., et al. Microbial co-occurrence relationships in the human microbiome. PLOS Comput Biol: 2012; 8 7 e1002606
12. Gevers D., Knight R., Petrosino J. F., et al. The Human Microbiome Project: a community resource for the healthy human microbiome. PLoS Biol: 2012; 10 8 e1001377
13. Lloyd-Price J., Abu-Ali G., Huttenhower C. The healthy human microbiome. Genome Med: 2016; 8 1 51
14. Arrieta M. C., Stiemsma L. T., Amenyogbe N., Brown E. M., Finlay B. The intestinal microbiome in early life: health and disease. Front Immunol: 2014; 5 427
15. Cho I., Blaser M. J. The human microbiome: at the interface of health and disease. Nat Rev Genet: 2012; 13 4 260 270
16. Buttó L. F., Schaubeck M., Haller D. Mechanisms of microbe-host interaction in Crohn's disease: dysbiosis vs. pathobiont selection. Front Immunol: 2015; 6 555
17. Darfeuille-Michaud A., Boudeau J., Bulois P., et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology: 2004; 127 2 412 421
18. Manichanh C., Borruel N., Casellas F., Guarner F. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol: 2012; 9 10 599 608
19. Quévrain E., Maubert M. A., Michon C., et al. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease. Gut: 2016; 65 3 415 425
20. Salonen A., de Vos W. M., Palva A. Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives. Microbiology: 2010; 156 Pt 11 3205 3215
21. Jeffery I. B., Quigley E. M., Öhman L., Simrén M., O'Toole P. W. The microbiota link to irritable bowel syndrome: an emerging story. Gut Microbes: 2012; 3 6 572 576
22. Hayes P. A., Fraher M. H., Quigley E. M. Irritable bowel syndrome: the role of food in pathogenesis and management. Gastroenterol Hepatol (N Y): 2014; 10 3 164 174
23. Qin N., Yang F., Li A., et al. Alterations of the human gut microbiome in liver cirrhosis. Nature: 2014; 513 7516 59 64
24. Quigley E. M., Monsour H. P. The gut microbiota and nonalcoholic fatty liver disease. Semin Liver Dis: 2015; 35 3 262 269
25. Llopis M., Cassard A. M., Wrzosek L., et al. Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease. Gut: 2016; 65 5 830 839
26. Vrieze A., Van Nood E., Holleman F., et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology: 2012; 143 4 913 6.e7
27. Hungate R. E. Symposium: selected topics in microbial ecology. I. Microbial ecology of the rumen. Bacteriol Rev: 1960; 24 4 353 364
28. Savage D. C. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol: 1977; 31 107 133
29. Sender R., Fuchs S., Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol: 2016; 14 8 e1002533
30. Woese C. R., Fox G. E. Phylogenetic structure of the prokaryotic domain: the primary kingdoms. Proc Natl Acad Sci U S A: 1977; 74 11 5088 5090
31. Medlin L., Elwood H. J., Stickel S., Sogin M. L. The characterization of enzymatically amplified eukaryotic 16S-like rRNA-coding regions. Gene: 1988; 71 2 491 499
32. Venter J. C., Remington K., Heidelberg J. F., et al. Environmental genome shotgun sequencing of the Sargasso Sea. Science: 2004; 304 5667 66 74
33. Eckburg P. B., Bik E. M., Bernstein C. N., et al. Diversity of the human intestinal microbial flora. Science: 2005; 308 5728 1635 1638
34. Schrader C., Schielke A., Ellerbroek L., Johne R. PCR inhibitors - occurrence, properties and removal. J Appl Microbiol: 2012; 113 5 1014 1026
35. Gohl D. M., Vangay P., Garbe J., et al. Systematic improvement of amplicon marker gene methods for increased accuracy in microbiome studies. Nat Biotechnol: 2016; 34 9 942 949
36. Klindworth A., Pruesse E., Schweer T., et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res: 2013; 41 1 e1
37. Flemer B., Lynch D. B., Brown J. M., et al. Tumour-associated and non-tumour-associated microbiota in colorectal cancer. Gut: 2016; gutjnl-2015-309595
38. Lu H., Ren Z., Li A., et al. Deep sequencing reveals microbiota dysbiosis of tongue coat in patients with liver carcinoma. Sci Rep: 2016; 6 33142
39. Baxter N. T., Ruffin M. T., Rogers M. AM, Schloss P. D. Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions. Genome Med: 2016; 8 1 37
40. Amaral-Zettler L. A., McCliment E. A., Ducklow H. W., Huse S. M. A method for studying protistan diversity using massively parallel sequencing of V9 hypervariable regions of small-subunit ribosomal RNA genes. PLoS One: 2009; 4 7 e6372
41. Singer E., Bushnell B., Coleman-Derr D., et al. High-resolution phylogenetic microbial community profiling. ISME J: 2016; 10 8 2020 2032
42. Caporaso J. G., Kuczynski J., Stombaugh J., et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods: 2010; 7 5 335 336
43. Schloss P. D., Westcott S. L., Ryabin T., et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol: 2009; 75 23 7537 7541
44. Edgar R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics: 2010; 26 19 2460 2461
45. Team R. CR. A language and environment for statistical computing. Vienna, Austria R Foundation for Statistical Computing: 2013
46. Kanehisa M., Goto S., Sato Y., Kawashima M., Furumichi M., Tanabe M. Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res: 2014; 42 Database issue D199 D205
47. Ashburner M., Ball C. A., Blake J. A., et al. The Gene Ontology Consortium. Gene ontology: tool for the unification of biology. Nat Genet: 2000; 25 1 25 29
48. Consortium H. MP.; Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature: 2012; 486 7402 207 214
49. Zeller G., Tap J., Voigt A. Y., et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol: 2014; 10 766
50. Castellarin M., Warren R. L., Freeman J. D., et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res: 2012; 22 2 299 306
51. Franzosa E. A., Morgan X. C., Segata N., et al. Relating the metatranscriptome and metagenome of the human gut. Proc Natl Acad Sci U S A: 2014; 111 22 E2329 E2338
52. Turnbaugh P. J., Ley R. E., Mahowald M. A., Magrini V., Mardis E. R., Gordon J. I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature: 2006; 444 7122 1027 1031
53. Muccioli G. G., Naslain D., Bäckhed F., et al. The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol: 2010; 6 392
54. Perry R. J., Peng L., Barry N. A., et al. Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome. Nature: 2016; 534 7606 213 217
55. Sayin S. I., Wahlström A., Felin J., et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab: 2013; 17 2 225 235
56. Le Chatelier E., Nielsen T., Qin J., et al. MetaHIT consortium. Richness of human gut microbiome correlates with metabolic markers. Nature: 2013; 500 7464 541 546
57. Zeevi D., Korem T., Zmora N., et al. Personalized nutrition by prediction of glycemic responses. Cell: 2015; 163 5 1079 1094
58. Rajilić-Stojanović M., Biagi E., Heilig H. G., et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology: 2011; 141 5 1792 1801
59. Carroll I. M., Ringel-Kulka T., Keku T. O., et al. Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol: 2011; 301 5 G799 G807
60. Jeffery I. B., O'Toole P. W., Öhman L., et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut: 2012; 61 7 997 1006
61. Sears C. L., Garrett W. S. Microbes, microbiota, and colon cancer. Cell Host Microbe: 2014; 15 3 317 328
62. Flynn K. J., Baxter N. T., Schloss P. D. Metabolic and community synergy of oral bacteria in colorectal cancer. mSphere: 2016; 1 3 102 116
63. Vipperla K., O'Keefe S. J. Diet, microbiota, and dysbiosis: a 'recipe' for colorectal cancer. Food Funct: 2016; 7 4 1731 1740
64. Yu J., Feng Q., Wong S. H., et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut: 2015; gutjnl-2015-309800
65. Zackular J. P., Rogers M. A., Ruffin M. T. IV, Schloss P. D. The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev Res (Phila): 2014; 7 11 1112 1121